dc.contributor.author | Kristoffersen, Per M | |
dc.contributor.author | Bråten, Lars Christian Haugli | |
dc.contributor.author | Vetti, Nils | |
dc.contributor.author | Grøvle, Lars | |
dc.contributor.author | Hellum, Christian | |
dc.contributor.author | Storheim, Kjersti | |
dc.contributor.author | Zwart, John-Anker | |
dc.contributor.author | Assmus, Jörg | |
dc.contributor.author | Espeland, Ansgar | |
dc.date.accessioned | 2021-01-26T13:41:03Z | |
dc.date.accessioned | 2021-03-15T08:56:42Z | |
dc.date.available | 2021-01-26T13:41:03Z | |
dc.date.available | 2021-03-15T08:56:42Z | |
dc.date.issued | 2020-11-27 | |
dc.identifier.citation | Kristoffersen PM, Bråten, Vetti, Grøvle, Hellum, Storheim, Zwart, Assmus, Espeland. Oedema on STIR modified the effect of amoxicillin as treatment for chronic low back pain with Modic changes-subgroup analysis of a randomized trial. European Radiology. 2020 | en |
dc.identifier.issn | 0938-7994 | |
dc.identifier.issn | 1432-1084 | |
dc.identifier.uri | https://hdl.handle.net/10642/10044 | |
dc.description.abstract | Objective To evaluate potential MRI-defined effect modifiers of amoxicillin treatment in patients with chronic low back pain and type 1 or 2 Modic changes (MCs) at the level of a previous lumbar disc herniation (index level). Methods: In a prospective trial (AIM), 180 patients (25–64 years; mean age 45; 105 women) were randomised to receive amoxicillin or placebo for 3 months. Primary outcome was the Roland-Morris Disability Questionnaire (RMDQ) score (0–24 scale) at 1 year. Mean RMDQ score difference between the groups at 1 year defined the treatment effect; 4 RMDQ points defined the minimal clinically important effect. Predefined baseline MRI features of MCs at the index level(s) were investigated as potential effect modifiers. The predefined primary hypothesis was a better effect of amoxicillin when short tau inversion recovery (STIR) shows more MC-related high signal. To evaluate this hypothesis, we pre-constructed a composite variable with three categories (STIR1/2/3). STIR3 implied MC-related STIR signal increases with volume ≥ 25% and height > 50% of vertebral body and maximum intensity increase ≥ 25% and presence on both sides of the disc. As pre-planned, interaction with treatment was analysed using ANCOVA in the per protocol population (n = 155). Results: The STIR3 composite group (n = 41) and STIR signal volume ≥ 25% alone (n = 45) modified the treatment effect of amoxicillin. As hypothesised, STIR3 patients reported the largest effect (− 5.1 RMDQ points; 95% CI − 8.2 to − 1.9; p for interaction = 0.008). Conclusions: Predefined subgroups with abundant MC-related index-level oedema on STIR modified the effect of amoxicillin. This finding needs replication and further support. | en |
dc.description.sponsorship | This study has received funding by the South East Norway Regional Health Authority (grant no. 2015-090) and the Western Norway Regional Health Authority (grant nos. HV 911891 and HV 911938). | en |
dc.language.iso | en | en |
dc.publisher | Springer | en |
dc.relation.ispartofseries | European Radiology; | |
dc.rights | Creative Commons Attribution 4.0 International (CC BY 4.0) License | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Magnetic resonance imaging | en |
dc.subject | Spines | en |
dc.subject | Low back pains | en |
dc.subject | Amoxicillin | en |
dc.subject | Prospective studies | en |
dc.title | Oedema on STIR modified the effect of amoxicillin as treatment for chronic low back pain with Modic changes-subgroup analysis of a randomized trial | en |
dc.type | Journal article | en |
dc.type | Peer reviewed | en |
dc.date.updated | 2021-01-26T13:41:03Z | |
dc.description.version | publishedVersion | en |
dc.identifier.doi | https://doi.org/10.1007/s00330-020-07542-w | |
dc.identifier.cristin | 1873652 | |
dc.source.journal | European Radiology | |